Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients-Reference-Cited by-同舟云学术

Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients

Published:2020-07-27 Issue:1 Volume:17 Page:7-17
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Vidoni Eric D.¹²,Choi In‐Young¹³²⁴,Lee Phil¹³⁴⁵,Reed Gregory⁶,Zhang Na⁶,Pleen Joseph¹²,Mahnken Jonathan D.¹⁷,Clutton Jonathan¹,Becker Annette¹,Sherry Erica¹,Bothwell Rebecca¹,Anderson Heidi¹,Harris Robert A.⁸,Brooks William¹³²⁴,Wilkins Heather M.¹²,Mosconi Lisa⁹,Burns Jeffrey M.¹²⁴,Swerdlow Russell H.¹²⁴⁸

Affiliation:

1. University of Kansas Alzheimer's Center Fairway Kansas USA

2. Department of Neurology Kansas University Medical Center Kansas City Kansas USA

3. Hoglund Biomedical Imaging Center Kansas City Kansas USA

4. Department of Molecular and Integrative Physiology Kansas University Medical Center Kansas City Kansas USA

5. Department of Radiology Kansas University Medical Center Kansas City Kansas USA

6. Department of Pharmacology and Toxicology Kansas University Medical Center Kansas City Kansas USA

7. Department of Biostatistics Kansas University Medical Center Kansas City Kansas USA

8. Biochemistry and Molecular Biology Kansas University Medical Center Kansas City Kansas USA

9. Department of Neurology Weill Cornell Medical College New York New York USA

Funder

Alzheimer's Association

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12156

Reference51 articles.

1. Treating Neurodegeneration by Modifying Mitochondria: Potential Solutions to a “Complex” Problem

2. Positron emission tomographic studies of aging and Alzheimer disease;Leon MJ;AJNR Am J Neuroradiol,1983

3. Positron Emission Tomography in Evaluation of Dementia

4. Altered cerebral energy metabolism in Alzheimer's disease: a PET study;Fukuyama H;J Nucl Med,1994

5. Brain Cytochrome Oxidase in Alzheimer's Disease

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dementia therapy: time for an energy boost;Brain;2024-04-26

2. Novel Approaches to the Establishment of Local Microenvironment from Resorbable Biomaterials in the Brain In Vitro Models;International Journal of Molecular Sciences;2023-09-28

3. The Alzheimer’s Disease Mitochondrial Cascade Hypothesis: A Current Overview;Journal of Alzheimer's Disease;2023-04-04

4. Oxaloacetate enhances and accelerates regeneration in young mice by promoting proliferation and mineralization;Frontiers in Cell and Developmental Biology;2023-02-24

5. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial;Journal of Translational Medicine;2022-06-28